Amarantus Bioscience Holdings Inc (AMBS)

[JJAAMMAANN]

Wonder when the FDA will let us know if an ODD was granted for Eltoprazine for PD-LID?

SAN FRANCISCO, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan indications and neurology, today announced that it has submitted a request to the US FDA for orphan drug designation (ODD) for Eltoprazine in the treatment of levodopa-induced dyskinesia (PD-LID).

http://www.amarantus.com/news/press-releases/detail/2027/amarantus-submits-orphan-drug-designation-application-to-us

Seeing how the 2B Study was already announced, then placed on hold, I am guessing that it would move along pretty quickly once the 2B was completed. Elto has been tested in human subjects for many years now, and hasn't shown any negative side effects. I would think a Big Pharma would jump all over this one if the ODD for exclusivity came back soon.

At this point, partnering with anything would be nice!

In My Own Personal Opinion Of Course!
Long AMBS!